Skip to main content
Log in

Low serum apolipoprotein AI levels in amyloidosis related to familial Mediterranean fever

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Amyloidosis (A) related to familial Mediterranean fever (FMF) causes serious morbidity and mortality in children. Our study evaluates serum levels of apolipoprotein (Apo) AI, AII, B, and E and Apo AII/AI ratios as a non-invasive diagnostic tool for amyloidosis in children with FMF and FMF-A. Results were compared with those of patients with childhood nephrotic syndrome (NS) and healthy children (controls). Significantly lower serum levels of Apo AI (90.20±28.30 mg/dl) were documented in patients with FMF-A than in all other groups (FMF 126.89±51.07 mg/dl, NS 140.38±33.73 mg/dl, and controls 134.67±12.73 mg/dl) (P<0.01). Diagnostic sensitivity, specificity, and predictive value for this test were 85%, 80%, and 85%, respectively. Apo AII/AI ratio results were essentially equal in all groups (P>0.05). It is concluded that a decreased Apo AI serum level, but not Apo AII/AI ratio, is a useful, non-invasive test for the early diagnosis of FMF-A in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43:227–253

    CAS  PubMed  Google Scholar 

  2. Pras E, Aksetijevich I, Gruberg L, Balow JE, Prosen L, Dean M, Steinberg AD, Pras M, Kastner DL (1992) Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 326:1509–1513

    CAS  PubMed  Google Scholar 

  3. Saatci U, Bakkaloglu A, Ozen S, Besbas N (1993) Familial Mediterranean fever and amyloidosis in children. Acta Paediatr 82:705–706

    CAS  PubMed  Google Scholar 

  4. Glenner GG (1980) Amyloid deposits and amyloidosis. The β-fibrilosis. N Engl J Med 136:1283

    Google Scholar 

  5. Robbins SL, Kumar V (1987) Amyloidosis. In: Robbins SL, Kumar V (eds). Basic pathology,4th edn. Saunders, Philadelphia, pp 214–221

  6. Gedalia A (2000) Amyloidosis. In: Behrman RE, Kliegman MR, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. Saunders, Philadelphia, pp 724–725

  7. Hawkins PN, Mayers MJ, Lavender JP, Pepys MB (1988) Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet I:1413–1418

    Google Scholar 

  8. Yamada T, Ozawa T, Gejyo F, Okuda Y, Takasugi K, Hotta O, Itoh Y (1988) Decreased serum apolipoprotein AII/AI ratio in systemic amyloidosis. Ann Rheum Dis 57:249–251

    Google Scholar 

  9. Ando Y, Tanaka Y, Ueyama H, Sakashita N, Yonekawa T, Higuchi K, Araki S (1993) Low plasma apolipoprotein AII levels in human and mouse amyloidosis with mutant transthretin (Met-30) gene. Ann Neurol 33:101–103

    CAS  PubMed  Google Scholar 

  10. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    CAS  PubMed  Google Scholar 

  11. International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564

    PubMed  Google Scholar 

  12. Burtis C, Ashward E (1994) Lipids, lipoproteins and apolipoproteins. In: Burtis C, Ashward E (eds) Tietz textbook of clinical chemistry, 2th edn. Saunders, Philadelphia, pp 1019–1024

  13. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the treatment and prevention of amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001–1005

    Google Scholar 

  14. Zemer D, Livneh A, Langevitz P (1992) Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever. Ann Intern Med 116:426

    CAS  Google Scholar 

  15. Simsek B, Islek I, Simsek T, Kucukoduk S, Cengiz K (2000) Regression of amyloidosis due to familial Mediterranean fever by colchicine. Nephrol Dial Trans 15:281–282

    Article  CAS  Google Scholar 

  16. Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623

    Article  PubMed  Google Scholar 

  17. Kocak H, Besbas N, Saatci U, Bakkaloglu A (1989) Amyloidosis in children with familial Mediterranean fever. Turk J Pediatr 31:281–287

    CAS  PubMed  Google Scholar 

  18. Tanaka Y, Ando Y, Kumamoto T, Miyazaki A, Nakamura M, Nakayama M, Araki S, Ando M (1994) Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I. Biochim Biophys Acta 1225:311–316

    Article  CAS  PubMed  Google Scholar 

  19. Kher KK (1992) Nephrotic syndrome. In: Kher KK, Makker SP (eds) Clinical pediatric nephrology. McGraw Hill, New York, pp 144–145

Download references

Acknowledgement

The authors wish to thank the critical review of the statistical analysis of Professor Dr. Yuksel Bek and Dr. Sevgi Canbaz.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to İsmail İşlek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

İşlek, İ., Şimşek, T., Baskın, E. et al. Low serum apolipoprotein AI levels in amyloidosis related to familial Mediterranean fever. Pediatr Nephrol 18, 1005–1008 (2003). https://doi.org/10.1007/s00467-003-1227-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1227-9

Keywords

Navigation